Research Summary
Bupivacaine Liposome Injection is a long-acting local anesthetic formulation that encapsulates bupivacaine, a commonly used pain-relieving drug, in liposomes. These liposomes, which are small lipid-based vesicles, help to gradually release the bupivacaine over an extended period, providing prolonged pain relief compared to traditional bupivacaine injections. This formulation is particularly useful for managing post-surgical pain, as it offers extended anesthesia without the need for repeated doses. Bupivacaine Liposome Injection is typically used in procedures like orthopedic, abdominal, and cardiac surgeries, where prolonged pain management is required. Its controlled release mechanism improves patient comfort by reducing the need for additional analgesics and minimizing the risk of side effects associated with frequent dosing.
According to DIResearch's in-depth investigation and research, the global Bupivacaine Liposome Injection market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Bupivacaine Liposome Injection include Pacira Pharmaceuticals, Jiangsu Hengrui Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Bupivacaine Liposome Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bupivacaine Liposome Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Bupivacaine Liposome Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bupivacaine Liposome Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Bupivacaine Liposome Injection Include:
Pacira Pharmaceuticals
Jiangsu Hengrui Pharma
Bupivacaine Liposome Injection Product Segment Include:
133mg per Vial
266mg per Vial
Bupivacaine Liposome Injection Product Application Include:
Hospital
Clinic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Bupivacaine Liposome Injection Industry PESTEL Analysis
Chapter 3: Global Bupivacaine Liposome Injection Industry Porter’s Five Forces Analysis
Chapter 4: Global Bupivacaine Liposome Injection Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Bupivacaine Liposome Injection Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Bupivacaine Liposome Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Bupivacaine Liposome Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Bupivacaine Liposome Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Bupivacaine Liposome Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Bupivacaine Liposome Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Bupivacaine Liposome Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Bupivacaine Liposome Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Bupivacaine Liposome Injection Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Bupivacaine Liposome Injection Product by Type
- 1.2.1 133mg per Vial
- 1.2.2 266mg per Vial
- 1.3 Bupivacaine Liposome Injection Product by Application
- 1.3.1 Hospital
- 1.3.2 Clinic
- 1.4 Global Bupivacaine Liposome Injection Market Revenue and Sales Analysis
- 1.4.1 Global Bupivacaine Liposome Injection Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Bupivacaine Liposome Injection Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Bupivacaine Liposome Injection Market Sales Price Trend Analysis (2020-2032)
- 1.5 Bupivacaine Liposome Injection Industry Trends and Innovation
- 1.5.1 Bupivacaine Liposome Injection Industry Trends and Innovation
- 1.5.2 Bupivacaine Liposome Injection Market Drivers and Challenges
- 2 Bupivacaine Liposome Injection Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Bupivacaine Liposome Injection Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Bupivacaine Liposome Injection Market Analysis by Regions
- 4.1 Bupivacaine Liposome Injection Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Bupivacaine Liposome Injection Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Bupivacaine Liposome Injection Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Bupivacaine Liposome Injection Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Bupivacaine Liposome Injection Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Bupivacaine Liposome Injection Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Bupivacaine Liposome Injection Sales Forecast by Region (2026-2032)
- 4.4 Global Bupivacaine Liposome Injection Sales Price Trend Analysis (2020-2032)
- 5 Global Bupivacaine Liposome Injection Market Size by Type and Application
- 5.1 Global Bupivacaine Liposome Injection Market Size by Type
- 5.1.1 Global Bupivacaine Liposome Injection Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Bupivacaine Liposome Injection Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Bupivacaine Liposome Injection Market Size by Application
- 5.2.1 Global Bupivacaine Liposome Injection Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Bupivacaine Liposome Injection Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Bupivacaine Liposome Injection Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Bupivacaine Liposome Injection Market Size by Type
- 6.3.1 North America Bupivacaine Liposome Injection Sales by Type (2020-2032)
- 6.3.2 North America Bupivacaine Liposome Injection Revenue by Type (2020-2032)
- 6.4 North America Bupivacaine Liposome Injection Market Size by Application
- 6.4.1 North America Bupivacaine Liposome Injection Sales by Application (2020-2032)
- 6.4.2 North America Bupivacaine Liposome Injection Revenue by Application (2020-2032)
- 6.5 North America Bupivacaine Liposome Injection Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Bupivacaine Liposome Injection Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Bupivacaine Liposome Injection Market Size by Type
- 7.3.1 Europe Bupivacaine Liposome Injection Sales by Type (2020-2032)
- 7.3.2 Europe Bupivacaine Liposome Injection Revenue by Type (2020-2032)
- 7.4 Europe Bupivacaine Liposome Injection Market Size by Application
- 7.4.1 Europe Bupivacaine Liposome Injection Sales by Application (2020-2032)
- 7.4.2 Europe Bupivacaine Liposome Injection Revenue by Application (2020-2032)
- 7.5 Europe Bupivacaine Liposome Injection Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Bupivacaine Liposome Injection Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Bupivacaine Liposome Injection Market Size by Type
- 8.3.1 China Bupivacaine Liposome Injection Sales by Type (2020-2032)
- 8.3.2 China Bupivacaine Liposome Injection Revenue by Type (2020-2032)
- 8.4 China Bupivacaine Liposome Injection Market Size by Application
- 8.4.1 China Bupivacaine Liposome Injection Sales by Application (2020-2032)
- 8.4.2 China Bupivacaine Liposome Injection Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Bupivacaine Liposome Injection Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Bupivacaine Liposome Injection Market Size by Type
- 9.3.1 APAC (excl. China) Bupivacaine Liposome Injection Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Bupivacaine Liposome Injection Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Bupivacaine Liposome Injection Market Size by Application
- 9.4.1 APAC (excl. China) Bupivacaine Liposome Injection Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Bupivacaine Liposome Injection Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Bupivacaine Liposome Injection Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Bupivacaine Liposome Injection Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Bupivacaine Liposome Injection Market Size by Type
- 10.3.1 Latin America Bupivacaine Liposome Injection Sales by Type (2020-2032)
- 10.3.2 Latin America Bupivacaine Liposome Injection Revenue by Type (2020-2032)
- 10.4 Latin America Bupivacaine Liposome Injection Market Size by Application
- 10.4.1 Latin America Bupivacaine Liposome Injection Sales by Application (2020-2032)
- 10.4.2 Latin America Bupivacaine Liposome Injection Revenue by Application (2020-2032)
- 10.5 Latin America Bupivacaine Liposome Injection Market Size by Country
- 10.6 Latin America Bupivacaine Liposome Injection Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Bupivacaine Liposome Injection Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Bupivacaine Liposome Injection Market Size by Type
- 11.3.1 Middle East & Africa Bupivacaine Liposome Injection Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Bupivacaine Liposome Injection Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Bupivacaine Liposome Injection Market Size by Application
- 11.4.1 Middle East & Africa Bupivacaine Liposome Injection Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Bupivacaine Liposome Injection Revenue by Application (2020-2032)
- 11.5 Middle East Bupivacaine Liposome Injection Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Bupivacaine Liposome Injection Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Bupivacaine Liposome Injection Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Bupivacaine Liposome Injection Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Bupivacaine Liposome Injection Average Sales Price by Manufacturers (2021-2025)
- 12.2 Bupivacaine Liposome Injection Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Bupivacaine Liposome Injection Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Pacira Pharmaceuticals
- 13.1.1 Pacira Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Portfolio
- 13.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Jiangsu Hengrui Pharma
- 13.2.1 Jiangsu Hengrui Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Portfolio
- 13.2.3 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Bupivacaine Liposome Injection Industry Chain Analysis
- 14.2 Bupivacaine Liposome Injection Industry Raw Material and Suppliers Analysis
- 14.2.1 Bupivacaine Liposome Injection Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Bupivacaine Liposome Injection Typical Downstream Customers
- 14.4 Bupivacaine Liposome Injection Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook